ONC vs ROIV
BeOne Medicines AG · Roivant Sciences Ltd.
Relative return (rebased to 100)
Key stats
| Metric | ONC | ROIV |
|---|---|---|
| Price | $399.70 | $38.96 |
| Market Cap | $593.53B | $28.23B |
| P/E | 2068.53 | — |
| P/B | 101.97 | 7.02 |
| P/S | 111.08 | 3417.54 |
| ROE | 4.9% | -7.5% |
| Net Margin | 5.4% | -3629.2% |
| Gross Margin | 87.5% | — |
| Revenue Growth | 40.2% | -71.6% |
| Dividend Yield | — | — |
| EPS | $0.19 | -$0.41 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.